NL-OMON21723尚未招募不适用
Efficacy of emollient, anti-inflammatory cream contining Isoleucine vs. standard emollient cream in children with facial atopic dermatitis (AD) with evaluation of facial EASI score
Investigator Sponsor TrialProf GL MarsegliaPediatric Clinic Ospdale San Matteo0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 80
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Children aged 1-12 years
- •Atopic Dermatitis mild to moderate
排除标准
- •Treatment with systemic anti-inflammatory drugs
研究者
相似试验
进行中（未招募）
1 期
Efficacy and tolerance of the emollient cream V0034 CR in the symptomatic treatment of ichthyosis in children. International, multicentric, randomised, controlled, double blind study, in parallel groups V0034 CR versus vehicle.EUCTR2006-003369-14-ESPIERRE FABRE MEDICAMENT265
进行中（未招募）
不适用
Efficacy and tolerance of the emollient cream V0034 CR in the symptomatic treatment of ichthyosis in children. International, multicentric, randomised, controlled, double blind study, in parallel groups V0034 CR versus vehicle.EUCTR2006-003369-14-FIPIERRE FABRE MEDICAMENT270
进行中（未招募）
1 期
Efficacy and tolerance of the emollient cream V0034 CR in the symptomatic treatment of ichthyosis in children. International, multicentric, randomised, controlled, double blind study, in parallel groups V0034 CR versus vehicle.EUCTR2006-003369-14-FRPIERRE FABRE MEDICAMENT265
进行中（未招募）
不适用
Efficacy and tolerance of the emollient cream V0034 CR in the symptomatic treatment of ichthyosis in children. International, multicentric, randomised, controlled, double blind study, in parallel groups V0034 CR versus vehicle.EUCTR2006-003369-14-DEPIERRE FABRE MEDICAMENT270
进行中（未招募）
不适用
Efficacy and tolerance of the emollient cream V0034 CR in the symptomatic treatment of ichthyosis in children. International, multicentric, randomised, controlled, double blind study, in parallel groups V0034 CR versus vehicle.Patients presenting with ichthyosisMedDRA version: 8.1Level: LLTClassification code 10021198Term: IchthyosisEUCTR2006-003369-14-LTPIERRE FABRE MEDICAMENT270